Appendix 2A - Application for quotation of securities Announcement Summary Entity name RADIOPHARM THERANOSTICS LIMITED Announcement Type New announcement Date of this announcement Tuesday

Announcement Summary

RADIOPHARM THERANOSTICS LIMITED

Date of this announcement

Tuesday January 21, 2025

The +securities to be quoted are:

Please refer to the response to Q2.3d for further information

about the type of securities to be quoted and the circumstances of the issue.

Total number of +securities to be quoted

Refer to next page for full details of the announcement

RADIOPHARM THERANOSTICS LIMITED

We (the entity named above) apply for +quotation of the

following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.4 The announcement is

1.5 Date of this announcement

2.1 The +securities to be quoted are:

Please refer to the response to Q2.3d for further information

about the type of securities to be quoted and the circumstances of the issue.

2.2 The +class of +securities to be quoted is:

Additional +securities in a class that is already quoted on

ASX ("existing class")

2.3c Have these +securities been offered under a +disclosure

2.3d Please provide any further information needed to

understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities

has not been previously announced to the market in an Appendix 3B

2.4 Any on-sale of the +securities to be quoted within

12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act

The publication of a cleansing notice under section 708A(5),

708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)

Part 3B - number and type of +securities to be

quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Additional +securities to be quoted in an existing class

ASX +security code and description

RAD : ORDINARY FULLY PAID

Will the +securities to be quoted rank equally in all

respects from their issue date with the existing issued +securities in that class?

Number of +securities to be quoted

Are the +securities being issued for a cash consideration?

Any other information the entity wishes to provide about

the +securities to be quoted

The purpose(s) for which the entity is issuing the securities

To raise additional working capital

Following the quotation of the +securities the subject

of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated

and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX

4.1 Quoted +securities (total number of each +class

of +securities quoted on ASX following the +quotation of the +securities subject of this application)

4.2 Unquoted +securities (total number of each +class of

+securities issued but not quoted on ASX)

5.1 Are the +securities being issued under an exception

in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1?

5.2 Has the entity obtained, or is it obtaining, +security

holder approval for the issue under listing rule 7.1?

5.2b Are any of the +securities being issued without

+security holder approval using the entity's 15% placement capacity under listing rule 7.1?

of the +securities being issued without +security holder approval using the entity's additional 10% placement capacity under listing

rule 7.1A (if applicable)?

5.2c.1 How many +securities are being issued without +security holder approval using the entity's additional 10% placement capacity under